| 发明名称 | Prevention of allergy in children | ||
| 摘要 | The present invention relates to a use of bacterial superantigens in the manufacture of a pharmaceutical composition for mucous membrane administration for the prevention of inflammatory disorders in newborn infants, such pharmaceutical compositions, as well as method for prevention of inflammatory disorders. | ||
| 申请公布号 | US9084751(B2) | 申请公布日期 | 2015.07.21 |
| 申请号 | US200912478326 | 申请日期 | 2009.06.04 |
| 申请人 | SWECURE AB | 发明人 | Alderberth Ingegerd;Rudin Anna;Wold Agnes E. |
| 分类号 | A61K39/085;A61K39/00 | 主分类号 | A61K39/085 |
| 代理机构 | Gesmer Updegrove LLP | 代理人 | Gesmer Updegrove LLP |
| 主权项 | 1. A method for reducing the incidence of an allergic disorder, the method comprising: administering a pharmaceutical composition onto a mucous membrane in a newborn human infant, wherein the pharmaceutical composition comprises a therapeutically effective dose of (i) at least one isolated Staphylococcus aureus superantigen or (ii) isolated Staphylococcus aureus bacteria, the pharmaceutical composition is administered to a newborn infant within 3 months after birth when it comprises isolated-Staphylococcus aureus superantigens, and the pharmaceutical composition is administered to a newborn infant within one week after birth when it comprises isolated Staphylococcus aureus bacteria. | ||
| 地址 | Stockolm SE | ||